OrbusNeich

is a Hong Kong-based medical device company that develops and commercializes balloon catheters for the treatment of vascular disease...
Read more
OrbusNeich Chairman & CEO: David Chien

Chairman & CEO

David Chien

CEO Approval Rating

88/100

Annual Revenue
$153.9M
Employees
1,249
Funding
$200M
Acquisitions
2

News

Mar 12, 2026
Marketscreener
OrbusNeich: OrbusNeich Medical Group Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2025
Mar 12, 2026
FinanzNachrichten
OrbusNeich: OrbusNeich Medical Group Holdings Limited: OrbusNeich Achieves Record-breaking Revenue, Sales Volume and Gross Profit in FY2025, Net Profit Rises to US$42 million, Final Dividend Increases by 20% to HK12 Cents per Share
Aug 15, 2025
FinanzNachrichten
OrbusNeich: OrbusNeich Medical Group Holdings Limited: OrbusNeich Records Growth in 2025 Interim Results, Revenue and Net Profit Reach US$83.6 Million and US$19.8 Million Respectively
Mar 07, 2025
FinanzNachrichten
OrbusNeich: OrbusNeich Medical Group Holdings Limited: OrbusNeich Achieves Fourth Consecutive Year of Revenue Growth with Record High Revenue of US$164.1 Million and Net Profit of US$39.7 Million
Mar 07, 2025
Marketscreener
OrbusNeich: OrbusNeich Medical Group Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2024
Sep 25, 2024
FinanzNachrichten
OrbusNeich: OrbusNeich Medical Group Holdings Limited: OrbusNeich Launches a High-Capacity Logistics Center in the Netherlands
Aug 16, 2024
Marketscreener
OrbusNeich: OrbusNeich Medical Group Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2024
Apr 24, 2024
ACN Newswire
Press Release: OrbusNeich : OrbusNeich's Joint Venture Kicks Off TricValve Clinical Trial in Mainland China
Mar 07, 2024
Marketscreener
OrbusNeich: OrbusNeich Medical Group Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Mar 07, 2024
ACN Newswire
Press Release: OrbusNeich : OrbusNeich Achieves Record-High Revenue and Net Profit of US$154 Million and US$45.1 Million Respectively, Recommends Final Dividend Payment of HK10 cents per Share

OrbusNeich Competitors

1Forerunner Medical
2Leao Medical
3Jiuhong
4Heart And Vascular Care, Pa. - Dr. Pradip Baiju, Facc, Fscai
5Rainforest Pharmacy
6Cvalakecounty
7Orlando Health Physician Group
8Heart Care Centers of Illinois
9The Cardiovascular Specialists
10Birminghamheart

Trending Companies